Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed Combined With Sirolimus in Relapsed or Refractory NSCLC
NCT00923273Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Feb 2008
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Feb 2008; status: terminated.
02
Drugs
sirolimus
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00923273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00923273.